Showing results (2861-2870 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|November 5, 2003
Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancerSilas C Martin, Dennis D Gagnon, Lucy Zhang, et al.Pharmacoeconomics|November 5, 2003
The cost effectiveness of Apligraf treatment of diabetic foot ulcersW Ken Redekop, Joseph McDonnell, Paul Verboom, et al.Pharmacoeconomics|September 10, 2003
Practical aspects of designing and conducting pharmacoeconomic studies in JapanJim Doherty, Keiko SatoPharmacoeconomics|September 18, 2003
Cost-effectiveness league tables: valuable guidance for decision makers?Josephine Mauskopf, Frans Rutten, Warren SchonfeldPharmacoeconomics|September 18, 2003
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's diseaseLinus JönssonPharmacoeconomics|September 18, 2003
A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in CanadaJean Maroun, Carl Asche, Françoise Romeyer, et al.Pharmacoeconomics|January 31, 2004
Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropeniaMarc Esser, Helmut BrunnerPharmacoeconomics|January 31, 2004
An evaluation of the cost effectiveness of drotrecogin alfa (activated) relative to the number of organ system failuresMadeline Betancourt, Peggy S McKinnon, R Michael Massanari, et al.Pharmacoeconomics|October 27, 2007
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysisAmanda R Patrick, Wolfgang C Winkelmayer, Jerry Avorn, et al.Pharmacoeconomics|September 7, 2007
Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literatureAndrew F ShorrPageof 336